Omnicell, Inc. (OMCL)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Omnicell, Inc. keeps $8 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Oct 29
in 49 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Omnicell, Inc.
Omnicell, Inc. (NASDAQ: OMCL) provides medication management technology and services for healthcare providers, combining automation, software, and pharmacy workflows across the medical information services area. The company generated $1.2 billion of revenue in FY2025 from hospital and health systems solutions, pharmacy platforms, and related support offerings.
Today's Snapshot
OMCL ended yesterday 0.7% down at 33.64.
Trading Volume
Below 10d avg (666.6K)
467.9K
vs S&P 500 Today
Moderate Underperformance
-0.23%
Updated: September 10, 2026 at 12:29 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$34.34 - $38.71Sell
- RSI (14)37.28Neutral
- Stochastic %K (14, 3, 3)31.50Neutral
- MACD Level (12, 26)-1.26Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.